NCT04932941 MP1032 Treatment in Patients With Moderate to Severe COVID-19 Status COMPLETED Phase PHASE2
NCT04925050 First-in-Human Study of VB0004 in Healthy Subjects and to Patients With Mild to Moderate Hypertension With Low Cardiovascular Risk Status UNKNOWN Phase PHASE1
NCT04902105 Drug-Drug Interaction Study to Evaluate the Effect of Inhibition of UGTs on the PK of Ecopipam and Its Active Metabolite Status COMPLETED Phase PHASE1
NCT04900038 A Clinical Trial of GSK3640254 + Dolutegravir (DTG) in Human Immunodeficiency Virus-1 Infected Treatment-naive Adults Status TERMINATED Phase PHASE2
NCT04893512 First-In-Human Study Of Orally Administered CoV2-OGEN1 In Healthy Subjects Status COMPLETED Phase PHASE1
NCT04885829 Comparative Study of 3 Tocilizumab Products in Normal Healthy Volunteeers Status COMPLETED Phase PHASE1
NCT04881461 A Study in Adults With Grass Pollen-induced Rhinoconjunctivitis Status COMPLETED Phase PHASE3
NCT04838301 Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04782297 Long Term Hemodialysis Catheters (LTHD) Post Market Clinical Follow up (PMCF) Status WITHDRAWN Phase N/A
NCT04764851 Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates Status TERMINATED Phase PHASE1